During the past decade, Kangwon National University Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 3 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kangwon National University Hospital" #1 sponsor was "Seung-Jung Park" with 32 trials, followed by "Seoul National University Hospital" with 8 trials sponsored, "Duk-Woo Park, MD" with 4 trials sponsored, "Pharmicell Co., Ltd." with 3 trials sponsored and "CardioVascular Research Foundation, Korea" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kangwon National University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 38 trials as a collaborator, "Abbott" with 5 trials as a collaborator, "KangWon National University Hospital" with 4 trials as a collaborator, "SMG-SNU Boramae Medical Center" with 4 trials as a collaborator and "Asan Medical Center" with 3 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Kangwon National University Hospital" are "Coronary Artery Disease" (33 trials), "Coronary Disease" (4 trials), "Coronary Stenosis" (3 trials), "Acute Coronary Syndrome" (2 trials) and "Alcoholic Cirrhosis" (2 trials). Many other conditions were trialed in "Kangwon National University Hospital" in a lesser frequency.

Most popular intervention types in "Kangwon National University Hospital" are "Drug" (27 trials), "Device" (25 trials), "Procedure" (6 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cypher" (3 trials), "Aspirin monotherapy" (2 trials), "Aspirin,Clopidogrel" (2 trials), "Cellgram-LC" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kangwon National University Hospital" are 72 trials for "All" genders.

Currently, there are NaN active trials in "Kangwon National University Hospital". undefined are not yet recruiting, 17 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Kangwon National University Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Kangwon National University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 10 trials that are defined as “Not Applicable".